Published in Hum Hered on February 26, 1998
Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br (1982) 3.39
Anaesthesia for the porphyric patient. Anaesthesia (1993) 3.12
The severe form of alpha thalassaemia is caused by a haemoglobin gene deletion. Nature (1974) 3.04
Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet (1987) 2.95
Blood-lead and hypertension. Lancet (1976) 2.82
Multiple origins of transcription in the 4.5 Kb upstream of the epsilon-globin gene. Cell (1983) 2.47
Environmental lead pollution in an urban soft-water area. Br Med J (1972) 2.28
Genetic aspects of tuberous sclerosis in the west of Scotland. J Med Genet (1989) 2.19
Delta-beta-thalassemia is due to a gene deletion. Cell (1976) 2.12
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem (1994) 2.06
Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med (1977) 1.91
The acute porphyrias. Lancet (1997) 1.80
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet (1996) 1.78
Efficient isolation of X chromosome-specific single-copy probes from a cosmid library of a human X/hamster hybrid-cell line: mapping of new probes close to the locus for X-linked mental retardation. Am J Hum Genet (1987) 1.77
Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology (1993) 1.76
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Low level exposure to lead. BMJ (1990) 1.67
The prevention of hepatitis. S Afr Med J (1994) 1.67
Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet (1986) 1.62
Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens (1992) 1.60
Microcephaly: genetic counselling and antenatal diagnosis after the birth of an affected child. Am J Med Genet (1987) 1.57
Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies. Prenat Diagn (1999) 1.55
Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol (1999) 1.54
Evidence for genetic heterogeneity in hereditary hydronephrosis caused by pelvi-ureteric junction obstruction, with one locus assigned to chromosome 6p. Hum Genet (1992) 1.53
Life satisfaction and quality in Korean War veterans five decades after the war. J Epidemiol Community Health (2009) 1.48
Free beta-hCG as first-trimester marker for fetal trisomy. Lancet (1992) 1.47
Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay. Prenat Diagn (1993) 1.47
Depression of delta-aminolaevulic acid dehydrase activity by ethanol in man and rat. Clin Sci (1971) 1.45
Genotype prediction in the fragile X syndrome. J Med Genet (1991) 1.45
Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet (1992) 1.44
Dyskeratosis congenita. J Med Genet (1988) 1.44
Re-assessment of risk factors for sporadic Salmonella serotype Enteritidis infections: a case-control study in five FoodNet Sites, 2002-2003. Epidemiol Infect (2006) 1.43
The cervical spine in fibrodysplasia ossificans progressiva. Br J Radiol (1982) 1.42
Thrombocytopenia with absent radii (TAR) syndrome: a new increased cellular radiosensitivity syndrome. Clin Oncol (R Coll Radiol) (1995) 1.40
Heat-stable and immunoreactive placental alkaline phosphatase in maternal serum from Down's syndrome and trisomy 18 pregnancies. Prenat Diagn (1996) 1.40
Role of chronic low-level lead exposure in the aetiology of mental retardation. Lancet (1975) 1.39
Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J (1973) 1.35
A new strategy for cryptic telomeric translocation screening in patients with idiopathic mental retardation. J Med Genet (1998) 1.33
Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut (2007) 1.31
Human globin gene expression and linkage in bone marrow and fetal liver. Proc Natl Acad Sci U S A (1975) 1.30
Renal insufficiency associated with excessive lead exposure. Br Med J (1977) 1.29
Treatment with haematin in acute hepatic porphyria. Q J Med (1981) 1.29
A structured assessment of newly qualified medical graduates. Med Educ (2005) 1.28
Non-penetrance in tuberous sclerosis. Lancet (1986) 1.23
Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol Sci (1999) 1.23
Human globin gene analysis for a patient with beta-o/delta beta-thalassemia. Proc Natl Acad Sci U S A (1975) 1.22
The neurotoxicology of lead. Neurotoxicology (1986) 1.22
Alternative sites of transcription initiation upstream of the canonical cap site in human gamma-globin and beta-globin genes. Nucleic Acids Res (1984) 1.20
Computer-assisted interactive three-dimensional planning for neurosurgical procedures. Neurosurgery (1996) 1.19
Porphyrias. Br J Anaesth (2000) 1.19
Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. Br J Clin Pharmacol (1980) 1.19
Tetraethyl-lead poisoning. Lancet (1972) 1.18
Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. Nucleic Acids Res (1994) 1.18
Haplotype distribution of the human phenylalanine hydroxylase locus in Scotland and Switzerland. Am J Hum Genet (1989) 1.17
Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet (1982) 1.15
Second trimester prenatal diagnosis of the Jarcho-Levin syndrome. Prenat Diagn (1987) 1.15
[Contribution of lead in drinking water to blood-lead]. Lancet (1977) 1.15
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients. Cancer (1973) 1.14
Genetic heterogeneity in tuberous sclerosis. Study of a large collaborative dataset. Ann N Y Acad Sci (1991) 1.14
Evidence for genetic heterogeneity in tuberous sclerosis. J Med Genet (1989) 1.14
Heme biosynthesis in Friend erythroleukemia cells: control by ferrochelatase. Proc Natl Acad Sci U S A (1979) 1.14
Food iron and lead absorption in humans. Am J Clin Nutr (1986) 1.13
Dysplasia epiphysialis hemimelica. A clinical and genetic study. J Bone Joint Surg Br (1983) 1.13
Effect of certain anaesthetic agents on the activity of rat hepatic delta-aminolaevulinate synthase. Br J Anaesth (1978) 1.13
Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. Nucleic Acids Res (1994) 1.13
Confirmation of CHD7 as a cause of CHARGE association identified by mapping a balanced chromosome translocation in affected monozygotic twins. J Med Genet (2005) 1.12
Various Bacillus Typhosus Antigens Used for the Macroscopic Widal. Am J Public Health Nations Health (1935) 1.12
Identification of a new missense point mutation in exon 4 of the Cu/Zn superoxide dismutase (SOD-1) gene in a family with amyotrophic lateral sclerosis. Hum Mol Genet (1994) 1.12
A B1 repetitive sequence near the mouse beta-major globin gene. Gene (1982) 1.12
Genetic aspects of fibrodysplasia ossificans progressiva. J Med Genet (1982) 1.12
Methylenetetrahydrofolate dehydrogenase from Clostridium formicoaceticum and methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate cyclohydrolase (combined) from Clostridium thermoaceticum. Methods Enzymol (1980) 1.11
Blood-lead and cadmium in human hypertension. J Environ Pathol Toxicol (1980) 1.09
Spondylothoracic and spondylocostal dysostosis. Hereditary forms of spinal deformity. J Bone Joint Surg Br (1988) 1.09
Fusion of liposomes containing conductance probes with black lipid films. Biochim Biophys Acta (1976) 1.08
Safe levels of cadmium intake to prevent renal toxicity in human subjects. Br J Nutr (2000) 1.08
Androgenic control of the harderian gland in the male golden hamster. J Endocrinol (1977) 1.08
Autonomic neuropathy in acute intermittent porphyria. J Neurol Neurosurg Psychiatry (1985) 1.07
Is lead in tap water still a public health problem? An observational study in Glasgow. BMJ (1996) 1.07
Randomized comparison between low-pressure laparoscopic cholecystectomy and gasless laparoscopic cholecystectomy. Surg Endosc (1999) 1.07
Oral absorption of lead and iron. Lancet (1980) 1.06
The psychosocial sequelae of a second-trimester termination of pregnancy for fetal abnormality. Prenat Diagn (1992) 1.05
Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age. Prenat Diagn (1991) 1.05
The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension (1993) 1.05
Purification and characterization of nicotinamide adenine dinucleotide-dependent methylenetetrahydrofolate dehydrogenase from Clostridium formicoaceticum. J Biol Chem (1974) 1.05
The effect of calcium on lead absorption in rats. Biochem J (1977) 1.05
Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland. J Med Screen (1994) 1.04
Maternal lead levels after alterations to water supply. Lancet (1981) 1.03
Successful abatement of lead exposure from water supplies in the West of Scotland. Environ Res (1985) 1.03
Lethal neonatal chondrodysplasias in the West of Scotland 1970-1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant. Am J Med Genet (1985) 1.03
Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase. Enzyme (1977) 1.03
Assignment of the human angiotensinogen gene to chromosome 1q42-q43 by nonisotopic in situ hybridization [corrected]. Genomics (1990) 1.02
Enzyme abnormalities in the porphyrias. Lancet (1977) 1.02
Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res (1981) 1.02
Mast cells in the hamster Harderian gland: sex differences, hormonal control and relationship to porphyrin. J Anat (1982) 1.01
Lead in water, infant diet and blood: the Glasgow Duplicate Diet Study. Sci Total Environ (1985) 1.01
Leptospiral antibodies in flying foxes in Australia. J Wildl Dis (2002) 1.01
Effect of carbamazepine on haem biosynthesis in man. Eur J Clin Invest (1984) 1.01
First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice. Prenat Diagn (2004) 1.00
A retrospective analysis of blood-lead in mentally retarded children. Lancet (1977) 1.00